Wire · technology
GenScript says AI drug discovery business doubled in report of first half revenue growth
◆ Sectors
Drug DiscoveryAI Frontier Models
◆ Source
◆ Verified
Fusion42 · 20 August 2026 · Fusion42 review
GenScript's AI drug discovery business doubled its revenue in the first half of the year, indicating significant growth and adoption of AI technologies in drug development.
This Wire brief sits within Fusion42's coverage of Drug Discovery and AI Frontier Models.
◆ ◆ The Wire takeaway
You now face a market where AI-driven drug discovery is proving its commercial value. Invest in AI capabilities for your drug discovery pipeline or risk falling behind in deal flow and innovation.
◆ Coverage
1 source · 20 Aug 2026
◆ Related on Wire
◆ Topics
Drug DiscoveryAI Frontier Modelsaidrug-discoveryhealthtechrevenue-growth